Wells Fargo & Company Penumbra Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Penumbra Inc stock. As of the latest transaction made, Wells Fargo & Company holds 39,506 shares of PEN stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,506

Previous 48,027 17.74%

Holding current value

$11.2 Million

Previous $9.32 Million 0.61%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$190.97 - $253.66 $1.63 Million - $2.16 Million	-8,521 Reduced 17.74%	39,506 $9.38 Million
Q3 2024 Nov 13, 2024	SELL	$163.64 - $210.12 $1.71 Million - $2.19 Million	-10,436 Reduced 17.85%	48,027 $9.32 Million
Q2 2024 Aug 13, 2024	SELL	$172.27 - $223.95 $89,063 - $115,782	-517 Reduced 0.88%	58,463 $10.5 Million
Q1 2024 May 10, 2024	BUY	$220.09 - $273.15 $646,184 - $801,968	2,936 Added 5.24%	58,980 $13.2 Million
Q4 2023 Feb 09, 2024	SELL	$181.44 - $260.22 $232,606 - $333,602	-1,282 Reduced 2.24%	56,044 $14.1 Million
Q3 2023 Nov 13, 2023	BUY	$240.69 - $338.77 $1.16 Million - $1.64 Million	4,836 Added 9.21%	57,326 $13.9 Million
Q2 2023 Aug 15, 2023	BUY	$271.54 - $344.06 $2.15 Million - $2.73 Million	7,925 Added 17.78%	52,490 $18.1 Million
Q1 2023 May 12, 2023	BUY	$220.43 - $278.69 $2.03 Million - $2.57 Million	9,216 Added 26.07%	44,565 $12.4 Million
Q4 2022 Feb 13, 2023	SELL	$151.88 - $228.5 $1.19 Million - $1.8 Million	-7,860 Reduced 18.19%	35,349 $7.86 Million
Q3 2022 Nov 14, 2022	SELL	$120.36 - $205.88 $136,247 - $233,056	-1,132 Reduced 2.55%	43,209 $8.19 Million
Q2 2022 Aug 12, 2022	SELL	$116.09 - $227.33 $658,810 - $1.29 Million	-5,675 Reduced 11.35%	44,341 $5.52 Million
Q1 2022 May 16, 2022	BUY	$187.51 - $283.98 $1.93 Million - $2.93 Million	10,308 Added 25.96%	50,016 $11.1 Million
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $164,275 - $198,720	690 Added 1.77%	39,708 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $311,143 - $361,428	1,241 Added 3.29%	39,018 $10.4 Million
Q2 2021 Aug 16, 2021	SELL	$235.0 - $310.7 $1.41 Million - $1.86 Million	-5,998 Reduced 13.7%	37,777 $10.4 Million
Q1 2021 May 13, 2021	SELL	$175.6 - $291.43 $1.38 Million - $2.29 Million	-7,846 Reduced 15.2%	43,775 $11.8 Million
Q4 2020 Feb 09, 2021	SELL	$174.98 - $272.83 $1.12 Million - $1.75 Million	-6,401 Reduced 11.03%	51,621 $9.03 Million
Q3 2020 Nov 05, 2020	SELL	$185.27 - $238.73 $610,279 - $786,376	-3,294 Reduced 5.37%	58,022 $11.3 Million
Q2 2020 Aug 13, 2020	BUY	$153.32 - $191.72 $551,798 - $690,000	3,599 Added 6.24%	61,316 $11 Million
Q1 2020 May 14, 2020	BUY	$124.34 - $193.76 $7.18 Million - $11.2 Million	57,717 New	57,717 $9.31 Million

Others Institutions Holding PEN

# of Institutions

409

Shares Held

29.2M

Call Options Held

254K

Put Options Held

43.3K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.7B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Penumbra Inc Transaction History